TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06813651: Safety, Tolerability and Efficacy of Adjunctive TBO-309 in Reperfusion for Stroke With Tandem Occlusion

Sponsor: ThromBio Pty. Ltd. · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 78 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$12,416,000

Rescue Site Savings

+$8,186,800

Unlock Full NCT06813651 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06813651 Rescue Dossier →